Onconetix, Inc. (ONCO) News
Follow Onconetix, Inc. (ONCO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 20 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Form SCHEDULE 13G/A Onconetix, Inc. Filed by: KEYSTONE CAPITAL PARTNERS, LLC
Filed on: November 5, 20
EQUITY | Nov 05, 2026, 06:55 PM UTC
L
Onconetix Advances Another $500,000 to Realbotix Under Financing Facility
Onconetix provided Realbotix LLC an additional $500,000 for growth initiatives and working capital, bringing total facility draws to $3 million. The non-interest-bearing facility will be cancelled and discharged in full
EQUITY | Oct 23, 2026, 12:35 PM UTC
L
Oncopeptides Completes SEK 100 Million Directed Share Issue
Oncopeptides completed a directed share issue of SEK 100 million.
EQUITY | Oct 14, 2026, 05:41 AM UTC
L
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones fo
MNA | Sep 24, 2026, 04:32 PM UTC
L
Onco-Innovations provides interim microsome study report across three species
Onco-Innovations Limited said it received interim results from its ong… microsome studies across three species, following its June 26, 2026 news release.
EQUITY | Sep 09, 2026, 10:00 PM UTC
L
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Manufacturing, IND and Capital Foundation Ahead of Planned Clinical Translation
Austin, Texas, September 9th, 2026, FinanceWireDisseminated on behalf of Onco-Innovations Ltd. and may include paid advertising.For biotechnology investors, a clear path to the clinic can be one of the most important ind
EQUITY | Sep 09, 2026, 03:41 PM UTC
L
Onco-Innovations enters debt settlement agreements, to issue shares
Onco-Innovations Limited says it entered into debt settlement agreements on September 8, 2026, with each agreement dated August 31, 2026.
EQUITY | Sep 08, 2026, 10:00 PM UTC
L
Onconetix targets Realbotix deal as Realbotix pilots humanoid robot events
Realbotix has launched a pilot using humanoid robots as presenters, hosts and brand ambassadors for live audiences, expanding beyond one-on-one interaction. Onconetix entered into a definitive agreement to acquire Realbo
MNA | Sep 03, 2026, 12:37 PM UTC
L
ONCO - Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in L
ONCO - Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
MNA | Sep 03, 2026, 12:30 PM UTC
L
Oncopeptides (Q2 Update): Growth Continues, with CEE Region Unlocked
Oncopeptides (Q2 Update): Growth Continues, with CEE Region Unlocked
EQUITY | Aug 31, 2026, 02:45 PM UTC
M
ONCO reports Q2 revenue up 62% YoY; margins highlighted
ONCO says Q2 revenue rose 62% YoY, citing strong margins and key milestones toward 2027 cash-flow positivity.
EQUITY | Aug 27, 2026, 08:08 AM UTC
M
ONCO Q2 2026 revenue up 62% YoY; margins strong
ONCO says Q2 2026 revenue rose 62% YoY with strong margins, and EMA review is ongoing for label expansion.
EQUITY | Aug 27, 2026, 07:05 AM UTC
L
Oncopeptides says Q2 net sales rose on Italy demand
Oncopeptides reported Q2 net sales rose on strong demand in Italy.
EQUITY | Aug 27, 2026, 06:17 AM UTC
M
ONCO reports Q2 2026 sales up 62% year-over-year
ONCO says Q2 2026 sales surged 62% year-over-year. Regulatory and geographic expansion is underway.
REGULATION | Aug 27, 2026, 06:02 AM UTC
M
Oncopeptides publishes Q2 2026 report
Oncopeptides publishes its Q2 2026 report.
EQUITY | Aug 27, 2026, 06:00 AM UTC
M
OncoForm Files For 100M Share Offering
OncoForm files S-1 for 100,000,000 shares of common stock
EQUITY | Aug 12, 2026, 05:54 PM UTC
L
Onconetix Appoints Ralph Schiess To Proteomedix Board
Onconetix appoints new board member
EQUITY | Aug 05, 2026, 12:31 PM UTC
L
ONCO Launches Robot Pilot
Onconetix's Realbotix launches humanoid robot and AI teacher's assistant pilot program in New York State school district
EQUITY | Jun 24, 2026, 12:30 PM UTC
L
ONCO Engages Nanosoft
Onco-Innovations engages Nanosoft Polymers to advance polymer and drug delivery development for ONC010
EQUITY | Jun 23, 2026, 10:03 PM UTC
M
Healthcare Stocks Move
Multiple healthcare stocks are moving in Tuesday's after-market session, with some rising and others falling
EQUITY | Jun 23, 2026, 09:09 PM UTC